GENE SILENCING AT THE DNA LEVEL
Dead / Abandoned — Abandoned — failure to respond (as of 18 Oct 2021)
What this means for you
This application is over — abandoned 06 Oct 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88949940
- Mark type
- Stylized text
- Filed
- 05 Jun 2020
- Abandoned
- 06 Oct 2021
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of platform technology, namely, developing a cancer immunotherapy computer platform for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; IT platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials
Owner
- Oncogenuity Inc., New York, NY, US
Prosecution history
- 18 Oct 2021 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 18 Oct 2021 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 05 Apr 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 05 Apr 2021 — FINAL REFUSAL E-MAILED
- 05 Apr 2021 — FINAL REFUSAL WRITTEN
- 16 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Sept 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Sept 2020 — NON-FINAL ACTION E-MAILED
- 16 Sept 2020 — NON-FINAL ACTION WRITTEN
- 09 Sept 2020 — ASSIGNED TO EXAMINER
- 26 Jun 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 09 Jun 2020 — NEW APPLICATION ENTERED